Antiproliferatiye effects of cyclopentenyl cytosine (NSC 375575) in human glioblastoma cells

Oncology Research

Volumn 9, Issue 3, 1997, Pages 111-118

  Agbaria, Riad ^a   Kelley, James A ^a   Jackman, Joany ^a   Viola, John J ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Blood brain barrier; CTP synthase; Cyclopentenyl cytosine; Glioblastoma; Intracerebral tumors

Indexed keywords

ANTINEOPLASTIC ANTIMETABOLITE; CYCLOPENTENYL CYTOSINE; CYTIDINE; CYTIDINE TRIPHOSPHATE; DRUG DERIVATIVE; GROWTH INHIBITOR; NUCLEOTIDE;

ADULT; ARTICLE; CASE REPORT; CELL CULTURE; CELL DIVISION; DOSE RESPONSE; DRUG EFFECT; GLIOBLASTOMA; HUMAN; MALE; METABOLISM; PATHOLOGY;

ADULT; ANTIMETABOLITES, ANTINEOPLASTIC; CELL DIVISION; CYTIDINE; CYTIDINE TRIPHOSPHATE; DOSE-RESPONSE RELATIONSHIP, DRUG; GLIOBLASTOMA; GROWTH INHIBITORS; HUMANS; MALE; NUCLEOTIDES; TUMOR CELLS, CULTURED;

EID: 0030624442     PISSN: 09650407     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Marquez, V. E.; Lim, M-I.; Treanor, S. P.; Plowman, J.; Priest, M. A.; Markovac, A.; Khan, M. S.; Kaskar, B.; Driscoll, J. S. Cyclopentenylcytosine: A carbocyclic nucleoside with antitumor and antiviral properties. J. Med. Chem. 31: 1687-1694; 1988.
2. Glazer, R. I.; Knode, M. C.; Lim, M-L.; Marquez, V. E. Cyclopentenyl cytidine analogue: An inhibitor of cytidine triphosphate synthesis in human colon carcinoma cells. Biochem. Pharmacol. 34:2535-2539; 1985.
3. Moyer, J. D.; Malinowski, N. M.; Treanor, S. P.; Marquez, V. E. Antitumor activity and biochemical effects of cyclopentenyl cytosine in mice. Cancer Res. 46:3325-3329; 1986.
4. Rang, G. J.; Cooney, D. A.; Moyer, J. D.; Kelley, J. A.; Kirn, H-Y.; Marquez, V. E.; Johns, D. G. Cyclopentenylcytosine triphosphate: Formation and inhibition of CTP synthetase. J. Biol. Chem. 264:713-718; 1989.
5. Grem, J. L.; Allegra, C. J. Enhancement of the toxicity and DNA incorporation of arabinosyl-5-azacytosine and 1-/3-Darabinofuranosylcytosine by cyclopentenyl cytosine. Cancer Res. 50:7279-7284; 1990.
6. Ford, H., Jr.; Cooney, D. A.; Ahluwalia, G. S.; Hao, Z.; Rommel, M. E.; Hicks, L.; Dobyns, K. A.; Tomaszewski, J. E.; Johns, D. G. Cellular pharmacology of cyclopentenyl cytosine in MOLT-4 lymphoblasts. Cancer Res. 51:37333740; 1991.
7. Yee, L. K.; Allegra, C. J.; Trepel, J. B.; Grem, J. L. Metabolism and RNA incorporation of cyclopentenyl cytosine in human colorectal cancer cells. Biochem. Pharmacol. 43:15871599; 1992.
8. Collins, J. M.; Klecker, R. W.; Kelley, J. A.; Roth, J. S.; McCully, C. L.; Balls, F. M.; Poplack, D. G. Pyrimidine dideoxyribonucleosides: Selectivity of penetration into cerebrospinal fluid. J. Pharmacol. Exp. Ther. 245:466-470; 1988.
9. Blaney, S. M.; Baus, F. M.; Hegedus, L.; Heideman, R. L.; McCully, C.; Murphy, R. F.; Kelley. J. A.; Poplack, D. G. Pharmacokinetics and metabolism of cyclopentenyl cytosine in nonhuman primates. Cancer Res. 50:7915-7919; 1990.
10. Politi, P, M.; Xie, F.; Dahut, W.; Ford, H., Jr.; Kelley, J. A.; Bastian, A.; Setser, A.; Allegra, C. J.; Chen, A. P.; Hamilton, J. M.; Arbuck, S. F.; Linz, P.; Brammer, H.; Grem, J. L. Phase I clinical trial of continuous infusion cyclopentenyl cytosine. Cancer Chemother. Pharmacol. 36:513-523; 1995.
11. Viola, J. J.; Agbaria, R.; Walbridge, S.; Oshiro, E. M.; Johns, D. G.; Kel.ley, J. A.; Oldfield, E. H.; Ram, Z. In situ cyclopentenyl cytosine infusion for the treatment of experimental brain tumors. Cancer Res. 55:1306-1309; 1995.
12. Burger, P. C.; Vogel, F. S. Surgical pathology of the nervous system and its coverings, 2nd ed. New York: John Wiley & Sons; 1982.
13. Riser, M. E. Tissue culture techniques. In: Schrader, W. T.; O'Malley, B. W., eds. Laboratory methods manual for hormone action and molecular endocrinology, 12th ed. Houston: Houston Biological Assoc., Inc.; 1988:14:3-14:38.
14. O'Connor, P. M.; Jackman, J.; Jondle, D.; Bhatia, K.; Magrath, 1.; Kohn, K. W. Role of the p53 tumor suppressor gene in cell cycle arrest and radiosensitivity of Burkitt's lymphoma cell lines. Cancer Res. 53:4776-4780; 1993.
15. Grossman, S. A. Chemotherapy of brain tumors. In: Sale-man, M., ed. Neurobiology of brain tumors. Vol. 4: Concepts in neurosurgery. Baltimore: Williams & Wilkins; 1991:321-340.
16. Morrison, P. F.; Laske, D. W.; Bobo, R. H.; Oldfield, E. H. High-flow microinfusion: Tissue penetration and pharmacodynamics. Am. J. Physiol. 266:R292-R305; 1994. .
17. Bobo, R. H.; Laske, D. W.; Akbasak, A.; Morrison, P. F.; Dedrick, R. L.; Oldfield, E. H. Convection-enhanced delivery of macromolecules in the brain. Proc. Natl. Acad. Sei USA 91:2076-2080;1994.
18. Agbaria, R.; Ford. H., Jr.; Kelley, J. A.; Xie, F., Politi, P.; Grem, J. L.; Cooney, D. A.; Marquez, V. E.; Allegra, C. J.; Johns, D. G. Measurement of cyclopentenyl cytosine 5'triphosphate in vitro and in vivo by multidimensional highperformance liquid chromatography. Anal. Biochem. 213:90-96; 1993.
19. Dobbins, D.; Kelley, J.; Allegra, C.; Grem, J< Intravenous infusion of cyclopentenyl cytosine (CPE-C) in the canine markedly inhibits the response to bilateral carotid occlusion. FASEB J. 11:A50; 1997.